$LFCR
Lifecore Biomedical, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$4.46
▲+0.00%+$0.000
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateLifecore Biomedical, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is LFCR up today? It is at $4.46 (+0.00%), and our scanner flagged it 5 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment LFCR spikes, and full due diligence on LFCR — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $LFCR 5 times in the last 30 days. Create a free account to track $LFCR, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on LFCR from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for LFCR today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystLIFECORE BIOMEDICAL, INC. \DE\: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →From the trading subreddits (WallStreetBets, r/stocks and more). Retail chatter, not a signal. Do your own research.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Houde Lovas Katrina Director | Acquired (grant/award) | +26K 0.07% of company | added 24% | 135K | n/a | Jun 4, 26 |
Johnson Paul Harold Director | Acquired (grant/award) | +26K 0.07% of company | added 59% | 70K | n/a | Jun 4, 26 |
Antunes Humberto Calheiros Director | Acquired (grant/award) | +26K 0.07% of company | added 55% | 73K | n/a | Jun 4, 26 |
Korenberg Matthew E Director | Acquired (grant/award) | +26K 0.07% of company | added 59% | 70K | n/a | Jun 4, 26 |
Schechter Joshua Director | Acquired (grant/award) | +26K 0.07% of company | added 24% | 133K | n/a | Jun 4, 26 |
Aryeh Jason Director | Acquired (grant/award) | +26K 0.07% of company | added 59% | 70K | n/a | Jun 4, 26 |
Obus Nelson Director | Acquired (grant/award) | +26K 0.07% of company | added 19% | 164K | n/a | Jun 4, 26 |
Kiper Christopher S Director | Acquired (grant/award) | +26K 0.07% of company | added 33% | 103K | n/a | Jun 4, 26 |
Josephs Paul Officer | Sold (automatic/other) | -40K 0.1% of company | sold 6.4% | 593K | $185K at $4.57 | May 20, 26 |
Salus Thomas D. Officer | Sold (automatic/other) | -25K 0.07% of company | sold 9.1% | 246K | $128K at $5.20 | Apr 14, 26 |
Salus Thomas D. Officer | Acquired (grant/award) | +30K 0.08% of company | added 12% | 271K | n/a | Mar 2, 26 |
Lake Ryan David Officer | Sold (automatic/other) | -23K 0.06% of company | sold 6.4% | 337K | $177K at $7.71 | Sep 3, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on LFCR from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for LFCR today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
LFCR last traded at $4.46, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The LFCR Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged LFCR 5 times in the last 30 days.
LFCR (Lifecore Biomedical, Inc. Common Stock) trades on XNAS, with a market cap of about $157M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge LFCR for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$LFCR discussion
Sign in to ask a question or join the discussion.